RecruitingNCT05364294
Molecular Diagnosis of Systemic Autoinflammatory Diseases
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Enrollment
300 participants
Start Date
May 18, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Systemic autoinflammatory diseases (SAIDs) are a set of rare clinically and genetically heterogeneous conditions. The project proposes to identify novel genes and specific signatures in subgroups of patients with SAIDs.
Eligibility
Min Age: 1 WeekMax Age: 120 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with genetic disease, inflammatory disease, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Week to 120 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05364294
Related Trials
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
NCT0245085133 locations
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
NCT011434543 locations
Rett Syndrome Registry
NCT0543234919 locations
Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN
NCT054990911 location
Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria
NCT033010381 location